TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Down 43.7% in December

TherapeuticsMD, Inc. (NASDAQ:TXMDGet Free Report) saw a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 12,000 shares, a decrease of 43.7% from the December 15th total of 21,300 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily volume of 275,000 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Ratings Changes

Separately, StockNews.com started coverage on TherapeuticsMD in a research note on Tuesday. They set a “hold” rating for the company.

Get Our Latest Analysis on TherapeuticsMD

TherapeuticsMD Trading Up 11.3 %

NASDAQ:TXMD traded up $0.11 during trading hours on Wednesday, reaching $1.11. The company had a trading volume of 92,440 shares, compared to its average volume of 1,818,736. TherapeuticsMD has a 1-year low of $0.70 and a 1-year high of $2.75. The business’s 50 day moving average price is $1.26 and its 200-day moving average price is $1.54.

Hedge Funds Weigh In On TherapeuticsMD

A hedge fund recently raised its stake in TherapeuticsMD stock. Clearline Capital LP raised its position in TherapeuticsMD, Inc. (NASDAQ:TXMDFree Report) by 18.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 636,622 shares of the company’s stock after buying an additional 101,282 shares during the period. Clearline Capital LP owned about 5.52% of TherapeuticsMD worth $1,025,000 at the end of the most recent quarter. Institutional investors own 30.74% of the company’s stock.

TherapeuticsMD Company Profile

(Get Free Report)

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.

See Also

Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.